Trials / Completed
CompletedNCT00947596
A Study of Inhaled Atropine Sulfate in Healthy Adults
Development of an Inhaled, Dry Powder Delivery System for the Administration of Atropine Sulfate
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 18 (estimated)
- Sponsor
- MicroDose Defense Products L.L.C. · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
MicroDose Defense Products, LLC is developing an atropine dry powder inhaler (ADPI). This pilot study compares the pharmacokinetics (PK) of inhaled dry powder atropine as delivered by the ADPI to atropine delivery from the AtroPen autoinjector.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | atropine sulfate | dry powder for inhalation |
| DRUG | atropine sulfate | intramuscular injection |
Timeline
- Start date
- 2009-08-01
- Primary completion
- 2010-07-01
- Completion
- 2010-08-01
- First posted
- 2009-07-28
- Last updated
- 2010-08-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00947596. Inclusion in this directory is not an endorsement.